+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Reagents - Global Strategic Business Report

  • PDF Icon

    Report

  • 232 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338910
The global market for Biotechnology Reagents was estimated at US$104.3 Billion in 2024 and is projected to reach US$135.1 Billion by 2030, growing at a CAGR of 4.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Biotechnology Reagents market.

Biotechnology Reagents - Key Trends and Drivers

Biotechnology reagents are critical in the realm of modern biotechnological research and applications, enabling a myriad of processes such as DNA cloning, sequencing, labeling, mutagenesis, and various polymerase chain reaction (PCR) methodologies. As central components in molecular biology, they support advanced genetic research, pharmacology, and diagnostics, with the development of new techniques necessitating an increased demand for specialized reagents and kits. This requirement is facilitating growth not only within established markets but also opening avenues in emerging fields where these reagents are integral to innovation and application expansion.

The global biotechnology reagents market is witnessing substantial growth fueled by significant investments in research and development from governments, academic institutions, and private sectors, particularly in areas such as stem cell research and synthetic biology. These investments are propelling advancements in CRISPR gene editing technology, next-generation sequencing (NGS), and personalized medicine, thereby increasing the need for high-quality reagents. The continuous expansion of biotechnological applications, coupled with the growing importance of diagnostics and biopharmaceuticals in healthcare, is boosting the demand for these specialized reagents.

Technological innovations within the sector are critical in driving the biotechnology reagents market forward, with developments in fluorescence-based assays, high-throughput screening technologies, and the production of biopharmaceuticals necessitating advanced reagents that offer higher sensitivity and specificity. The expansion of the diagnostics sector, spurred by the COVID-19 pandemic and the increasing prevalence of chronic diseases, further underscores the need for precise diagnostic reagents. Additionally, the growing trend of collaborations between academic and commercial entities to expedite the commercialization of research is enhancing the demand for sophisticated biotechnology reagents, supporting the dynamic growth of this market.

SCOPE OF STUDY:

The report analyzes the Biotechnology Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Technology (Chromatography, In-vitro Diagnostics, PCR, Cell Culture, Other Technologies)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Chromatography segment, which is expected to reach US$40.6 Billion by 2030 with a CAGR of a 3.4%. The In-vitro Diagnostics segment is also set to grow at 3.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $27.8 Billion in 2024, and China, forecasted to grow at an impressive 7.3% CAGR to reach $28.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biotechnology Reagents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotechnology Reagents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biotechnology Reagents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Molecular, Inc., Agilent Technologies, Inc., BD Biosciences, bioMerieux SA, Bio-Rad Laboratories, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 267 companies featured in this Biotechnology Reagents market report include:

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Biotechnology Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Investments in Life Sciences Research Propels Growth in Biotechnology Reagents Market
Technological Advancements Drive Adoption of Next-Generation Sequencing Reagents
Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
Innovations in CRISPR and Gene Editing Technologies Accelerate Demand for Specialized Reagents
Growing Use of Stem Cells Spurs Market Growth for Advanced Reagents
Focus on Regenerative Medicine Throws the Spotlight on Tissue Engineering Reagents
Expansion of Biotechnology Industry Generates Demand for High-Quality Reagents
Rising Prevalence of Chronic Diseases Fuel Demand for Diagnostic Reagents
Development of Synthetic and Animal-Free Reagents Strengthens Business Case for Ethical Research
Shift towards Automation in Laboratories Expands Addressable Market Opportunity
Focus on High-Throughput Screening Technologies Drives Adoption of Automated Reagents
Growing Popularity of Organoid Research Impacts Market Dynamics
Rising Awareness of Cell Therapy Applications Generates Demand for Advanced Reagents
Integration of AI and Machine Learning Throws the Spotlight on Predictive Reagents Models
Adoption of Advanced Imaging Techniques Strengthens Business Case for High-Resolution Reagents
Focus on Reducing Contamination Risk Generates Demand for Sterile Reagents
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Biotechnology Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for In-vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: USA 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: Canada 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
JAPAN
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 26: Japan Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Japan Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: Japan 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
CHINA
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 29: China Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: China Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: China 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
EUROPE
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 32: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: Europe Historic Review for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: Europe 15-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 35: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: Europe 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
FRANCE
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 38: France Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: France Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: France 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
GERMANY
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 41: Germany Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Germany Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Germany 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Italy Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Italy 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
UNITED KINGDOM
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 47: UK Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: UK Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: UK 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
SPAIN
TABLE 50: Spain Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Spain Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Spain 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
RUSSIA
TABLE 53: Russia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Russia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Russia 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Rest of Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Rest of Europe 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 60: Asia-Pacific Historic Review for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Asia-Pacific 15-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Asia-Pacific Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Asia-Pacific 15-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2015, 2025 & 2030
AUSTRALIA
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

Table Information